Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis
Open Access
Abstract
Background. Synovial sarcoma can present morphologically in multiple forms, including biphasic and monophasic subtypes. As a result, the histological diagnosis can sometimes be challenging. Transducin-Like Enhancer 1 (TLE1) is a transcriptional corepressor that normally is involved in embryogenesis and hematopoiesis but is also expressed in certain tumors. This systematic review examines the potential role of TLE1 as a diagnostic biomarker for the synovial sarcoma. Materials and Methods. A literature review and meta-analysis were conducted using the electronic databases Pubmed, the Cochrane Library, and Google Scholar. Thirteen studies met our eligibility criteria and were selected for in-depth analysis. Results. The mean sensitivity and specificity of TLE1 in detecting synovial sarcoma were 94% (95% CI 91%–97%) and 81% (95% CI 72%–91%), respectively, when all studies were aggregated together. The mean positive predictive value (PPV) of TLE1 was 75% (95% CI 62%–87%), whereas the negative predictive value (NPV) was 96% (95% CI 93%–98%). Conclusion. TLE1 is a sensitive and specific marker for synovial sarcoma that can aid in its diagnosis. Due to its involvement in several relevant signaling pathways, TLE1 might have direct relevance to the pathophysiology of the disease.Keywords
This publication has 48 references indexed in Scilit:
- Specificity of TLE1 Expression in Unclassified High-grade Sarcomas for the Diagnosis of Synovial SarcomaApplied Immunohistochemistry & Molecular Morphology, 2013
- Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new casesTumor Biology, 2012
- TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomasVirchows Archiv, 2011
- TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): Analysis of 319 casesEuropean Journal of Cancer, 2010
- Prospective Evaluation of TLE1 as a Diagnostic Immunohistochemical Marker in Synovial SarcomaAmerican Journal of Surgical Pathology, 2009
- TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasmsLaboratory Investigation, 2009
- Groucho binds two conserved regions of LEF-1 for HDAC-dependent repressionBMC Cancer, 2009
- The Groucho/TLE/Grg family of transcriptional co-repressorsGenome Biology, 2008
- β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activationNature Structural & Molecular Biology, 2005
- A novel fusion gene, SS18L1/SSX1, in synovial sarcomaGenes, Chromosomes and Cancer, 2003